Details of the Target
General Information of Target
Target Site Mutations in Different Cell Lines
Cell line | Mutation details | Probe for labeling this protein in this cell | |||
---|---|---|---|---|---|
HCT15 | SNV: p.A239V; p.T444I | . | |||
ICC12 | SNV: p.I412F | . | |||
NCIH1155 | Insertion: p.R138PfsTer8 | . | |||
NCIH146 | SNV: p.H559L | DBIA Probe Info | |||
NCIH3122 | SNV: p.E580G | . | |||
RPMI8226 | SNV: p.L599R | . | |||
SHP77 | SNV: p.G95E | DBIA Probe Info |
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
A-EBA Probe Info |
![]() |
4.71 | LDD0215 | [1] | |
W1 Probe Info |
![]() |
23.42 | LDD0235 | [2] | |
C-Sul Probe Info |
![]() |
3.91 | LDD0066 | [3] | |
YN-4 Probe Info |
![]() |
100.00 | LDD0445 | [4] | |
STPyne Probe Info |
![]() |
K229(8.49); K298(6.59); K438(6.65); K499(4.35) | LDD0277 | [5] | |
ONAyne Probe Info |
![]() |
K229(6.21); K298(10.00) | LDD0275 | [5] | |
OPA-S-S-alkyne Probe Info |
![]() |
K229(5.69); K499(7.98); K438(10.03) | LDD3494 | [6] | |
DBIA Probe Info |
![]() |
C97(2.08) | LDD3314 | [7] | |
Johansson_61 Probe Info |
![]() |
_(20.00) | LDD1485 | [8] | |
IA-alkyne Probe Info |
![]() |
N.A. | LDD0036 | [9] | |
Lodoacetamide azide Probe Info |
![]() |
N.A. | LDD0037 | [9] | |
2PCA Probe Info |
![]() |
N.A. | LDD0034 | [10] | |
ATP probe Probe Info |
![]() |
N.A. | LDD0035 | [11] | |
WYneN Probe Info |
![]() |
N.A. | LDD0021 | [12] | |
IPM Probe Info |
![]() |
N.A. | LDD0005 | [12] | |
Acrolein Probe Info |
![]() |
N.A. | LDD0217 | [13] | |
TER-AC Probe Info |
![]() |
N.A. | LDD0426 | [14] |
PAL-AfBPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
STS-1 Probe Info |
![]() |
N.A. | LDD0137 | [15] | |
STS-2 Probe Info |
![]() |
N.A. | LDD0138 | [15] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0108 | Chloroacetamide | HeLa | C58(0.00); C289(0.00) | LDD0222 | [13] |
LDCM0569 | Fragment7 | Jurkat | _(20.00) | LDD1485 | [8] |
LDCM0022 | KB02 | 42-MG-BA | C58(1.38) | LDD2244 | [7] |
LDCM0023 | KB03 | 42-MG-BA | C58(1.48) | LDD2661 | [7] |
LDCM0024 | KB05 | IGR37 | C97(2.08) | LDD3314 | [7] |
LDCM0109 | NEM | HeLa | C289(0.00); C501(0.00) | LDD0231 | [13] |
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Transporter and channel
Other
The Drug(s) Related To This Target
Approved
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Activated Recombinant Fvii-albumin Fusion Protein | . | D0C0CE |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Vobarilizumab | Antibody | D9J6XV | |||
Ru-101 | . | D0YW6P |
Investigative
Discontinued
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Zomepirac | Small molecular drug | DB04828 |
References